4.7 Article

Assessing gene-level translational control from ribosome profiling

Journal

BIOINFORMATICS
Volume 29, Issue 23, Pages 2995-3002

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btt533

Keywords

-

Funding

  1. Prostate Cancer Foundation (PCF) Young Investigator Awards
  2. Burroughs Wellcome Fund Career Award for Medical Scientists
  3. David H. Koch Foundation
  4. National Institutes of Health [4R37EB002784-35, F32CA162634, 1K08CA175154-01, P30 CA82103, R01CA154916, R01CA140456]

Ask authors/readers for more resources

Motivation: The translational landscape of diverse cellular systems remains largely uncharacterized. A detailed understanding of the control of gene expression at the level of messenger RNA translation is vital to elucidating a systems-level view of complex molecular programs in the cell. Establishing the degree to which such post-transcriptional regulation can mediate specific phenotypes is similarly critical to elucidating the molecular pathogenesis of diseases such as cancer. Recently, methods for massively parallel sequencing of ribosome-bound fragments of messenger RNA have begun to uncover genome-wide translational control at codon resolution. Despite its promise for deeply characterizing mammalian proteomes, few analytical methods exist for the comprehensive analysis of this paired RNA and ribosome data. Results: We describe the Babel framework, an analytical methodology for assessing the significance of changes in translational regulation within cells and between conditions. This approach facilitates the analysis of translation genome-wide while allowing statistically principled gene-level inference. Babel is based on an errors-in-variables regression model that uses the negative binomial distribution and draws inference using a parametric bootstrap approach. We demonstrate the operating characteristics of Babel on simulated data and use its gene-level inference to extend prior analyses significantly, discovering new translationally regulated modules under mammalian target of rapamycin (mTOR) pathway signaling control.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available